DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

DRESS syndrome

Essential points for quick revision.

!
DRESS is a multisystem emergency

Fever, extensive rash, facial oedema, haematological abnormality and internal-organ injury can progress after the culprit medicine has been stopped.

Action: Admit suspected significant DRESS, stop non-essential culprit medicines, involve dermatology and the affected-organ teams, and repeat organ assessment because early results may be deceptively mild.

Synopsis

Recognise delayed drug reaction with eosinophilia and systemic symptoms, withdraw the likely culprit promptly, assess organ involvement serially, and prevent dangerous re-exposure.

  • Suspect DRESS when a widespread drug eruption appears two to eight weeks after exposure with fever, facial oedema, nodes, eosinophilia or organ injury.
  • Examine for infiltrated oedema, especially face and ears, but recognise active erythema may appear violaceous, grey or brown in deeply pigmented skin.
  • List every medicine taken during the preceding two months, including antibiotics already completed and dose escalation of long-term treatments.

Key red flags

Jaundice, coagulopathy, chest pain, breathlessness, hypotension, reduced urine output, confusion, severe abdominal pain or rapidly worsening blood tests requires urgent critical and organ-specialist care.

Internal-organ injury

Jaundice, renal change, breathlessness, chest pain, hypotension or neurological symptoms can indicate life-threatening visceral disease.

Investigation priorities

01
Full medicine chronologyFirst step

Rank plausible culprits using exposure dates, known latency, dose and organ phenotype.

Management branches

Probable DRESSWithdraw and map organ involvement

A delayed drug eruption includes fever, facial oedema, blood abnormalities or any internal-organ signal.

  1. Stop plausible non-essential culprits, admit when systemic involvement is significant and obtain dermatology plus acute-medical review.
  2. Apply a structured diagnostic framework and assess blood, liver, kidney, urine and symptom-directed cardiac, lung or pancreatic involvement.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom